Have your say: A Clinician’s Perspective on the Role of Gastric Cancer Patient-Derived Organoids in Precision Medicine
We’re inviting clinicians to take part in a short 5-minute survey and share their insights on the use of patient-derived organoids to personalise chemotherapy for patients with non-curative gastric adenocarcinoma. Your insights will help guide future research and assess how this emerging technology could be integrated into clinical practice.
Open to oncologists, surgeons, gastroenterologists, radiation oncologists, trainees, and other cancer care professionals
Optional: Add your name/email to be acknowledged as part of the Gastric Cancer Organoid Survey Group and receive authorship on resulting publications
Click here to take the survey: https://redcap.link/GastricCancerOrganoidSurvey
Gallery
Related Articles
We've Published Abstracts from our 2024 Annual Scientific Meeting
The Executive are pleased to announce publication of submitted abstracts from the NZSG-NZgNC Annual Scientific Meeting
NZSG-NZgNC Annual Scientific Meeting Call for Abstracts Now Open
Abstract submissions are now open and close at 5pm on Friday 8 August 2025.
IBD Research Review Issue 70
Read about the latest IBD research and upcoming conferences.